|
HS Code |
533851 |
| Product Name | 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate |
| Cas Number | 124330-52-7 |
| Molecular Formula | C8H12N2O3S |
| Molecular Weight | 216.26 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C (Refrigerated) |
| Synonyms | None reported |
| Stability | Stable under recommended storage conditions |
| Smiles | CC1=NC(=NC(=C1SCC(=O)O)C)N.H2O |
As an accredited 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tightly sealed 25g plastic bottle with tamper-evident cap, labeled with chemical name, formula, batch number, and hazard symbols. |
| Shipping | The shipping of **2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate** is conducted in compliance with chemical safety regulations. The product is securely packaged in sealed containers to prevent moisture and contamination, clearly labeled, and accompanied by a Safety Data Sheet (SDS). Standard shipping avoids extreme temperatures and ensures prompt, tracked delivery. |
| Storage | 2-(Carboxymethylthio)-4,6-dimethylpyrimidine monohydrate should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, ideally at room temperature (15-25°C). Avoid exposure to strong acids, bases, and oxidizing agents. Ensure proper labeling and secure storage to prevent unauthorized access and accidental spillage. |
Applications of 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate in Industrial ManufacturingWe supply 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate as a specialty intermediate for use in specific pharmaceutical, agrochemical, and specialty chemical production streams. Below, we outline its established industrial applications, accompanied by technical and regulatory details recognized by our key international manufacturing clients. 1. Pharmaceutical Intermediate in Antiviral Active Pharmaceutical Ingredient (API) SynthesisThis compound serves as a core building block in synthesizing select pyrimidine-based APIs, especially for small-molecule antivirals addressing RNA viruses. Production teams use it during the nucleoside analogue assembly, where its unique substitution pattern supports efficient heterocycle formation under controlled conditions, minimizing impurity profiles required by regulatory authorities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Key Intermediate in Agrochemical Pyrimidine Herbicide ProductionAgrochemical manufacturers utilize this raw material as an intermediate in constructing novel pyrimidine-ring herbicides, particularly for selective pre-emergence products. The structure enables functionalization at positions crucial for bioactivity against grass and broadleaf weeds, meeting crop protection industry demands for improved selectivity and environmental compatibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Heterocyclic Dye and Pigment SynthesisSpecialty chemical and colorant producers apply this compound as a functionalized pyrimidine source, essential to creating stable chromophoric nuclei for advanced organic, water-soluble dyes. Its side chain carboxymethylthio group introduces controlled reactivity for subsequent diazo-coupling or sulfur-bridging, resulting in colorfast pigments required for textile and specialty ink industries. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Intermediate for Specialty Polymer Modifier SynthesisProducers of high-performance specialty polymers use this material to introduce pyrimidine-derived pendant groups, precisely modifying polymer backbones to tune surface energy, hydrophilicity, or thermal stability. The compound’s bifunctional nature allows it to participate in controlled co-polymerization or post-polymer modification processes, frequently in electronic-grade and filtration membrane sectors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Year after year, the fields of pharmaceuticals, crop protection, and advanced research call for intermediates with increasing precision. Having spent the last decade overseeing every stage of 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate production, we have come to value the exacting control over process variables that makes or breaks downstream performance. My team spends full weeks charting column purities and running solubility comparisons, not for show, but because materials on this scale anchor innovation and output up and down supply chains.
Anyone can look up its molecular formula, but those formulas are only as reliable as the batches behind them. Industry chatter rarely touches on the hassle caused by a missing hydrate or an overlooked impurity. The monohydrate form, with its consistent structure, keeps both yield and performance predictable; skipping these details leads to failures that waste months of work. Having our own reactors, handling every step from raw thioethers to the final crystallization, allows us to guarantee what ends up inside each drum matches the documentation every time. That is the difference between a manufacturer and a repacker – experience gives us authority over the details that matter most in your process.
We monitor the pH, moisture content, residual solvents, and crystalline structure batch by batch. Out-of-spec batches do not make it to the filling line. It comes off the dryer as a pale to off-white solid, and that uniformity proves essential in large-scale synthesis. For every reaction where stoichiometry matters, a small deviation can force adjustments in your entire protocol. Dimethylpyrimidine derivatives, especially the 2-(Carboxymethylthio) variant, have shown a tendency to pick up stray water or form minor side-products if storage and drying protocols slip. We track those details not because they look good on a certificate, but because the absence of variance acts as an insurance policy for our customers who trust their entire production cycle to this starting material.
We supply it consistent as a monohydrate, since the single water molecule present in the crystalline lattice stabilizes it over time, helping prevent degradation that might occur in the anhydrous state. Months of storage in sealed kegs or bags remain uneventful, and that protects both potency and safety for users in process development. Not every competitor invests in the thin margins that keep impurities low and content uniform. The analytical costs add up, but the field results repay them many times over. Researchers in agrochemical synthesis or advanced pharmaceutical work often find that off-the-shelf intermediates from traders introduce delays. We have worked with customers caught by these delays, and have rebuilt confidence through strict process control and transparent documentation.
Handling the monohydrate involves several choices, from specialized drying ovens to batch-specific packaging. The choice is not academic but practical. Monohydrate stability makes life easier in actual production environments. Moisture content influences both analytical chemistry and end-product synthesis, especially when scaling from grams to kilograms or tonnes. Keeping it in the monohydrate state eliminates the headaches of variable conversion rates in subsequent synthetic steps. In contrast, competing materials—sometimes carelessly labeled as “anhydrous”—can register unexpected reactivity and introduce yield loss, especially where sensitive coupling or methylation reactions follow.
In our lines, batch variants never cross. We never blend material from inconsistent sources to pad out lots. This attention limits batch-to-batch fluctuation, enabling your research teams to skip revalidation protocols that would otherwise slow delivery of new molecules to clinics or fields. We share spectral data and chromatograms for every lot with our customers; most synthetic bottlenecks, we have learned, stem from avoidable variation at the origin.
Typical specs go beyond a simple purity threshold. We report on assay by HPLC, loss on drying (to confirm monohydrate state), residue on ignition, and often, a full panel of heavy metals or potential chlorinated derivatives. These steps come from painful experience: a batch from a cut-rate intermediary once shut down a partner’s pilot line due to an unidentified side-product. Since then, we have committed to monitoring every lot not only for main content but side impurities down to trace levels. Analytical transparency does more than fill a datasheet; it removes the surprises that drive up project costs and timelines.
Specifications also impact application. Our production runs allow for precise control over particle size, ideal for users who require either rapid dissolution or minimal dust during transfer. We run stability tests under a range of temperature and humidity conditions every quarter. Learnings from pilot batches have taught us practical steps for managing shelf life; simple things like foil-lined packaging or secondary containment can extend product reliability far beyond the nominal expiry. Years of feedback from customers in regulated industries have led us to adopt these small but practical modifications as standard, not luxury options. We do not let cost-cutting threaten consistency.
Academic groups champion 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate for its core role building nitrogen-rich heterocycles. In formulation laboratories, it demonstrates high coupling efficiency and reliable behavior under basic and acidic synthesis zones. This efficiency comes not from theoretical properties but from empirical reliability—batch after batch. Our in-house synthesis teams routinely produce derivatives for use in advanced active ingredients. Reliability means less time wasted on troubleshooting, more spent running new reactions. Inconsistent supply chains, seen with intermediates sourced from less experienced vendors, lead to waste and, occasionally, regulatory headaches when trace impurities show up in final products.
Production chemistry rewards predictability. A kilo-scale batch that matches micro-scale trial purity means scale-up provides actionable results, not fresh headaches. Engineers and chemists who have banged their head against mysterious yield drops know the pain of uncertainty; most times, a root cause analysis points back to intermediate quality. We have supplied kilogram and tonne quantities to process plants and observed firsthand that robust impurity control averts the need for costly reprocessing.
Users also highlight its strong shelf-life stability and handling ease. Our customers appreciate being able to open a drum weeks or months after receipt and see no caking, no off-odors, and zero crystals stuck to packaging. This does not come about through luck, but through attention to the drying regime, packaging line, and warehouse practices: factors that avoid off-spec material slipping into process lines.
The chemical industry likes to talk about “solutions,” but we see most problems as challenges demanding gritty attention to detail. A run of subpar intermediate will throw off the schedule of a pharmaceutical pilot, while an order delayed by warehouse issues can disrupt an agricultural campaign. Our team tracks every lot barcode through synthesis, quality control, packing, and shipping. If a customer flags an issue, we can trace each step to identify the root cause and make changes that mean it doesn’t happen again. This data-driven feedback has eliminated recurring headaches and allowed partners to avoid rolling delays across product lines.
We do not rely on third-party bottling or anonymous subcontractors. Every milligram comes through vessels, dryers, and hoppers we maintain and calibrate ourselves. This complete lack of intermediaries provides unmatched transparency and quick adjustment in response to process feedback. In one instance, a long-term customer reported unexpected flow issues with our material during their tableting process. Instead of passing along half-hearted apologies or generic technical bulletins, we pulled production logs and made adjustments in crystal habit formation to eliminate sticking. We take these lessons to future batches so that improvements become standard operating practice, not one-off fixes.
Other forms of 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine appear in the market, often under vague descriptions—anhydrous, dihydrate, or “moist.” Based on controlled testing, anhydrous variants seldom show either improved reactivity or storage performance and often degrade faster if not immediately used. This exposes process chemists to the twin headaches of guessing water content and recalculating dosages for every step. Slow, costly, and unreliable, those methods pale next to the monohydrate, which stays the same for every operator and every batch. Customers who have switched from inconsistent sources regularly report reduced scrap rates and smoother process documentation.
Blended hydrates or inconsistent drying in some supply streams introduce even bigger questions. Multimodal forms can drive unpredictable melting points or decomposition profiles, leading to lower yield or inconsistent behavior during downstream processing. Staff must then adjust every new batch—sometimes mid-campaign—risking a shutdown or loss of key data. Our monohydrate, produced under fixed conditions every time, avoids these uncertainties. This is not just theory but comes from years of field reports and open conversations with process chemists under pressure to deliver both quality and quantity on schedule.
From an operational standpoint, packaging and traceability present their own set of headaches. Since this compound is sensitive to both humidity and mechanical abrasion, we package it in food-grade liners and, for bulk shipments, double-walled drums. Labels display actual moisture content and test dates; we avoid the “repotting” that introduces contaminants. Distribution relies on temperature- and humidity-controlled carriers, allowing customers to receive each shipment in the same crystalline state we released it from our site. Most large-scale intermediates do not get this degree of care, and customers who have tried both standard and premium-grade supplies recognize this difference after only a few batches. Receiving departments have less dust, less material loss, and warehouse managers enjoy clean inventory audits without a string of “suspect” lots set aside for extra testing.
Time after time, handling feedback from diverse industries—from bench chemists to plant operators—drives improvements in our logistic chain. We take every customer complaint seriously; resolution does not sit with a call center but goes directly to production engineers. This loop has led to stronger packaging tear resistance, upgraded dessicant insertions, and better lot tracking. Attention to these “small” problems prevents big ones at scale.
Researchers developing novel molecules count on the consistency only direct manufacturers can provide. A single contaminant can shadow an entire reaction pathway, especially in medicinal chemistry where compound purity determines therapeutic value. We routinely collaborate with R&D laboratories preparing scale-up documentation, using detailed batch histories that allow full regulatory compliance and smooth technology transfer. The headaches caused by variation—a persistent frustration among scientists—disappear when every container matches the last.
Our support doesn’t stop at shipment. Feedback from dozens of laboratories shapes technical bulletins and regular tweaks to particle size or packaging specifications. Project managers in process development speak plainly about the value of this dialogue: fewer protocol changes, reduced validation runs, and confidence during regulatory inspections. Downstream use in fine chemicals synthesis, specialty agrochemicals, and advanced pharmaceutical intermediates all benefit from this “known quantity.”
Behind every batch stands a crew of experienced operators who respect the risks and rewards of fine chemical synthesis. Veteran technicians do not rush drying at the expense of uniformity. Line supervisors quiz incoming raw materials for off-odors or unexpected hues. This hands-on attention catches issues otherwise missed by automated systems. Our QA protocols blend instrument data with operator experience; seasoned staff have seen enough batches to spot subtle inconsistencies, preventing material that looks “fine” on a graph from causing trouble in our customers’ critical syntheses.
This human element means modifications suggested by real users—such as a preference for larger granules in high-shear mixers, or extra dryness for a reactive application—can quickly impact process design. As a result, chemists and project managers find fewer surprises and less friction, even when pushing the boundaries of what this intermediate can do.
No two chemical projects follow a textbook path. Each day in production brings new wrinkles, whether from fluctuating raw material markets or shifting end-user application needs. Only by holding tight to process discipline and responding directly to user reports do we deliver intermediates like 2-(Carboxymethylthio)-4,6-Dimethylpyrimidine Monohydrate at the standard demanded by top-tier research and industry. Whether tackling kilo-scale synthesis or maintaining a global supply chain, the unglamorous work of keeping specifications tight, batches clean, and communication open forms the backbone of success in specialty chemicals. We’ve learned that a focus on fundamentals wins trust in the long run.
Real innovation at the bulk chemical level often means saying yes to minor fixes that ripple out to major efficiency gains. One plant user found caking during a humid summer, leading us to rethink dryer calibration cycles. A pharma customer flagged a spectral anomaly; cross-checking a fresh batch uncovered a raw material lot with marginally elevated organosulfur content, now blocked automatically by incoming QA. These improvements, grounded in open communication, come from years of lessons learned and applied to every new container heading to partners worldwide.
The world keeps changing—regulations tighten, project timelines get shorter, and customers demand more certainty for each project dollar. In our experience, the most sustainable edge comes from investing where it counts: full process transparency, traceable lot control, and hands-on engineer involvement at every stage. That is what sets apart a manufacturer’s product from those moved by traders or brokers whose priority is quick turnover. For us, a product is more than a number or a formula; it’s a promise backed by both people and practice, batch after batch.